Q1 2026 Holdings
Filed 2026-05-14 | 31 holdings | $712.2M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2026-06-12) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $52.4M | 579,161 | 7.4% |
| Schein Henry Inc(HSIC) | COM | 806407102 | $46.0M | 624,037 | 6.5% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $43.9M | 279,210 | 6.2% |
| Pfizer Inc(PFE)A | COM | 717081103 | $41.1M | 1,464,129 | 5.8% |
| Dexcom Inc(DXCM) | COM | 252131107 | $33.8M | 538,762 | 4.8% |
| ICU MED Inc(ICUI) | COM | 44930G107 | $32.8M | 254,291 | 4.6% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $31.9M | 194,909 | 4.5% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $31.2M | 67,681 | 4.4% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $30.7M | 315,972 | 4.3% |
| Globus MED Inc(GMED) | CL A | 379577208 | $30.5M | 354,350 | 4.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $27.7M | 209,932 | 3.9% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $26.1M | 1,359,969 | 3.7% |
| PTC Therapeutics Inc(PTCT)A | COM | 69366J200 | $25.6M | 376,165 | 3.6% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $22.4M | 1,504,536 | 3.1% |
| Elanco Animal Health Inc(ELAN) | COM | 28414H103 | $22.3M | 931,121 | 3.1% |
| Pacs Group Inc(PACS)A | COM SHS | 69380Q107 | $19.4M | 604,180 | 2.7% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $19.0M | 20,696 | 2.7% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $18.9M | 249,401 | 2.7% |
| Integer Hldgs Corp(ITGR) | COM | 45826H109 | $18.7M | 213,027 | 2.6% |
| Biogen Inc(BIIB) | COM | 09062X103 | $17.7M | 96,289 | 2.5% |
| Evommune Inc(EVMN) | COM SHS | 30054Y107 | $15.6M | 678,589 | 2.2% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $14.6M | 761,905 | 2.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $13.6M | 352,590 | 1.9% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $13.3M | 129,950 | 1.9% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $12.6M | 1,487,645 | 1.8% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $11.9M | 51,895 | 1.7% |
| Align Technology Inc(ALGN) | COM | 016255101 | $11.5M | 67,332 | 1.6% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $11.0M | 3,564,127 | 1.5% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $10.7M | 842,928 | 1.5% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $2.7M | 315,944 | 0.4% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $2.5M | 7,558,756 | 0.4% |